Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil

被引：20
|
作者：
Fasola, CG [1 ]
Netto, GJ [1 ]
Jennings, LW [1 ]
Christensen, LL [1 ]
Molmenti, EP [1 ]
Sanchez, EQ [1 ]
Levy, MF [1 ]
Goldstein, RM [1 ]
Klintmalm, GB [1 ]
机构：
[1] Baylor Univ, Med Ctr, Transplantat Serv, Dallas, TX 75246 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(02)03023-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1563 / 1564
页数：2
相关论文
共 50 条
  • [21] Successful rescue therapy with mycophenolate mofetil in liver transplant recipients
    Graziadei, L
    Schulz, F
    Nachbaur, K
    Königsrainer, A
    Margreiter, R
    Vogel, W
    TRANSPLANTATION, 1999, 67 (07) : S192 - S192
  • [22] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporin.
    Lobritto, SJ
    Rosenthal, P
    Bouw, R
    Leung, M
    Snell, P
    Mamelok, R
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 114 - 115
  • [23] The use of mycophenolate mofetil in transplant recipients
    Mele, TS
    Halloran, PF
    IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 215 - 245
  • [24] Liver function tests in mycophenolate mofetil-treated hepatitis C virus-positive kidney allograft recipients
    Ribeiro, AR
    Veronese, FV
    Manfro, RC
    Gonçalves, LF
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) : 489 - 490
  • [25] Mycophenolate Mofetil at the Time of Transplant Is an Important Independent Predictor of Early Hepatitis C Recurrence.
    Weimert, Nicole A.
    Taber, David J.
    Scheffert, Jenna L.
    Patel, Neha
    Dunn, Brianne D.
    Hughes, Michael G.
    Baliga, Prabhakar K.
    Chavin, Kenneth D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 524 - 524
  • [26] Optimization of the Dosing Regimen of Mycophenolate Mofetil in Pediatric Liver Transplant Recipients
    Barau, Caroline
    Barrail-Tran, Aurelie
    Hemerziu, Bogdan
    Habes, Dalila
    Taburet, Anne-Marie
    Debray, Dominique
    Furlan, Valerie
    LIVER TRANSPLANTATION, 2011, 17 (10) : 1152 - 1158
  • [27] Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients
    Barau, C.
    Barrail-Tran, A.
    Habes, D.
    Hermeziu, B.
    Taburet, A. M.
    Debray, D.
    Furlan, V
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 536 - 536
  • [28] Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroids
    Treckmann, J.
    Paul, A.
    Oezcelik, A.
    Saner, F.
    Malago, M.
    Nadalin, S.
    Lang, H.
    Malamutman, E.
    Gerken, G.
    Broeisch, C. E.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3234 - 3236
  • [29] Mycophenolate mofetil doses are too low in pediatric liver transplant recipients
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (2): : 64 - 64
  • [30] Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil
    Herrero, JI
    Quiroga, J
    Sangro, B
    Girala, M
    Gomez-Manero, N
    Pardo, F
    Alvarez-Cienfuegos, J
    Prieto, J
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (05): : 414 - 420
12345